BioMedix receives FDA warning letter
Device Regulation Alert: Safety, Compliance and Reimbursement News, January 3, 2008
BioMedix Vascular Solutions failed to follow current Good Manufacturing Practices at its St. Paul, MN, facility that manufactures the PADnet+ noninvasive cardiovascular blood flow monitoring system, according to an FDA warning letter.
The warning letter says BioMedix failed to:
- Ensure a quality system was fully implemented and maintained at all levels of the organization
- Investigate complaints about possible device failure
- Implement procedures for corrective and preventive actions
- Conduct quality audits at regular intervals
BioMedix also allegedly referred to the PADnet+ as FDA approved in brochures, even though the FDA has not approved the device.
Comments
0 comments on “BioMedix receives FDA warning letter ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Complete Guide to Lab Safety, 3rd Ed.
The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched